JUPITER Trial Study Group. Reduction in C-reactive protein and LDL cholesterol and cardiovascular event rates after initiation of rosuvastatin: a prospective study of the JUPITER trial - Ridker, PM; Danielson, E; Fonseca, FA (Lancet, 2009)
et al.